Application of Tumor Treating Fields (TTFields) to tumor cells augments their membrane permeability

被引：0
|
作者：
Koltun, B. [1 ]
Voloshin, T. [1 ]
Kan, T. [1 ]
Koren, L. [1 ]
Porat, Y. [1 ]
Volodin, A. [1 ]
Kaynan, N. [1 ]
Klein-Goldberg, A. [1 ]
Paz, R. [1 ]
Brant, B. [1 ]
Barsheshet, Y. [1 ]
Zemer-Tov, E. [1 ]
Ehrle, S. [2 ]
Haber, A. [1 ]
Giladi, M. [1 ]
Weinberg, U. [1 ]
Palti, Y. [1 ]
机构：
[1] Novocure Ltd, Haifa, Israel
[2] Novocure GmbH, Munich, Germany
来源：
STRAHLENTHERAPIE UND ONKOLOGIE | 2022年 / 198卷 / SUPPL 1期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
P07-1
引用
收藏
页码：S95 / S95
页数：1
相关论文
共 50 条
  • [41] Framework for Tumor Treating Fields (TTFields) dosimetry and treatment planning
    Kinzel, A.
    Bomzon, Z.
    Berger, B.
    Urman, N.
    Bakalo, O.
    Vardi, M.
    Shany, N.
    Zigelman, G.
    Naveh, A.
    Levi, S.
    Federov, E.
    STRAHLENTHERAPIE UND ONKOLOGIE, 2021, 197 (SUPPL 1) : S227 - S227
  • [42] Concomitant application of temozolomide, Tumor Treating Fields (TTFields), and lomustine in glioblastoma cells in vitro indicates better efficacy
    Fishman, H.
    Monin, R.
    Dor-On, E.
    Haber, A.
    Ehrle, S.
    Giladi, M.
    Weinberg, U.
    Palti, Y.
    STRAHLENTHERAPIE UND ONKOLOGIE, 2022, 198 (SUPPL 1) : S79 - S79
  • [43] Efficacy of concomitant application of Tumor Treating Fields (TTFields), temozolomide and lomustine in glio blastoma cancer cells in vitro
    Fishman, Hila
    Monin, Roni
    Dor-On, Eyal
    Haber, Adi
    Giladi, Moshe
    Weinberg, Uri
    Palti, Yoram
    CANCER RESEARCH, 2022, 82 (12)
  • [44] Tumor Treating Fields (TTFields): New Perspectives for Cancer Therapy
    不详
    ONCOLOGY RESEARCH AND TREATMENT, 2019, 42 (10) : 543 - 543
  • [45] GLIOBLASTOMA CELLS FROM A PATIENT POST-TUMOR TREATING FIELDS (TTFIELDS) THERAPY ARE SENSITIVE TO TTFIELDS IN VITRO
    Michelhaugh, Sharon K.
    Kiousis, Sam
    Mittal, Sandeep
    NEURO-ONCOLOGY, 2017, 19 : 87 - 87
  • [46] LONGTERM SURVIVAL AFTER TUMOR TREATING FIELDS (TTFIELDS) THERAPY
    Rulseh, A.
    Sroubek, J.
    Klener, J.
    Vymazal, J.
    NEURO-ONCOLOGY, 2017, 19 : 81 - 81
  • [47] Effects of tumor treating fields (TTFields) on glioblastoma cells are augmented by mitotic checkpoint inhibition
    Almuth F. Kessler
    Greta E. Frömbling
    Franziska Gross
    Mirja Hahn
    Wilfrid Dzokou
    Ralf-Ingo Ernestus
    Mario Löhr
    Carsten Hagemann
    Cell Death Discovery, 4
  • [48] Tumor Treating Fields (TTFields) together with PARP inhibitors for treatment of pancreatic cancer cells
    Martinez-Conde, Antonia
    Ene, Hila
    Ben-Meir, Kerem
    Dor-On, Eyal
    Lamichhane, Puru
    Haber, Adi
    Giladi, Moshe
    Palti, Yoram
    CANCER RESEARCH, 2024, 84 (02)
  • [49] Effects of tumor treating fields (TTFields) on glioblastoma cells are augmented by mitotic checkpoint inhibition
    Kessler, Almuth F.
    Froembling, Greta E.
    Gross, Franziska
    Hahn, Mirja
    Dzokou, Wilfrid
    Ernestus, Ralf-Ingo
    Loehr, Mario
    Hagemann, Carsten
    CELL DEATH DISCOVERY, 2018, 4
  • [50] Cancer cells upregulate autophagy as a survival mechanism in response to tumor treating fields (TTFields)
    Porat, Yaara
    Shteingauz, Anna
    Giladi, Moshe
    Schneiderman, Rosa S.
    Voloshin, Tali
    Munster, Mijal
    Blat, Roni
    Kirson, Eilon D.
    Weinberg, Uri
    Palti, Yoram
    CANCER RESEARCH, 2017, 77
12345